Millennium Management LLC Decreases Stake in Azenta, Inc. (NASDAQ:AZTA)

Millennium Management LLC lessened its holdings in Azenta, Inc. (NASDAQ:AZTAFree Report) by 42.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,646 shares of the company’s stock after selling 36,076 shares during the quarter. Millennium Management LLC owned about 0.09% of Azenta worth $2,612,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of AZTA. HighPoint Advisor Group LLC purchased a new position in Azenta in the 4th quarter valued at $364,000. Park Avenue Securities LLC raised its holdings in Azenta by 1.6% in the 1st quarter. Park Avenue Securities LLC now owns 12,181 shares of the company’s stock valued at $734,000 after buying an additional 192 shares during the period. Roble Belko & Company Inc purchased a new stake in Azenta in the 1st quarter valued at about $211,000. Norden Group LLC purchased a new stake in Azenta in the 1st quarter valued at about $1,720,000. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in Azenta in the 1st quarter valued at about $38,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Evercore ISI dropped their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research report on Tuesday, October 1st. Needham & Company LLC restated a “buy” rating and set a $69.00 target price on shares of Azenta in a research note on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $66.40.

Read Our Latest Analysis on AZTA

Azenta Stock Down 1.1 %

AZTA opened at $45.00 on Wednesday. The firm has a market cap of $2.43 billion, a P/E ratio of -16.61 and a beta of 1.47. Azenta, Inc. has a 52 week low of $43.65 and a 52 week high of $69.16. The business’s fifty day simple moving average is $48.75 and its 200 day simple moving average is $52.20.

Azenta (NASDAQ:AZTAGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.09. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. The company had revenue of $173.00 million for the quarter, compared to the consensus estimate of $166.14 million. During the same period last year, the business posted $0.13 EPS. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. As a group, equities analysts expect that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Recommended Stories

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.